US SB1221 | 2009-2010 | 111th Congress

Status

Sponsorship: Slight Partisan Bill (Democrat 7-4)
Status: Introduced on June 9 2009 - 25% progression, died in chamber
Action: 2009-06-09 - Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S6384)
Text: Latest bill text (Introduced) [PDF]

Summary

Amends title XVIII (Medicare) of the Social Security Act with respect to the use of average sales price methodology for calculating payments for drugs and biologicals under Medicare part B (Supplementary Medical Insurance). Excludes from the manufacturer's average sales price when calculating such payments any customary prompt pay discounts extended to wholesalers.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.

Sponsors


History

DateChamberAction
2009-06-09 Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S6384)
2009-06-09 Sponsor introductory remarks on measure. (CR S6383-6384)

Same As/Similar To

HB1392 (Same As) 2009-03-10 - Referred to the Subcommittee on Health.

Subjects


US Congress State Sources


feedback